Related Experiment Video
Updated: Jan 22, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
The genetics of Alzheimer disease
1Genetics and Aging Research Unit, Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA. tanzi@helix.mgh.harvard.edu
Genetic factors significantly contribute to Alzheimer disease (AD) risk. Rare mutations cause early-onset familial AD, while common gene variants like APOE influence late-onset AD susceptibility.
Area of Science:
- Neuroscience
- Genetics
- Gerontology
Background:
- Family history is a major risk factor for Alzheimer disease (AD), second only to advanced age.
- Genetic factors are implicated in at least 80% of AD cases, highlighting the importance of genetic research.
- AD inheritance shows a dual pattern: rare mutations for early-onset familial AD and common polymorphisms for late-onset AD.
Purpose of the Study:
- To review the current understanding of the genetic underpinnings of Alzheimer disease.
- To explore the historical progression and future directions in AD genetic research.
- To elucidate the complex and heterogeneous genetic factors contributing to AD.
Main Methods:
- Review of existing literature on Alzheimer disease genetics.
- Analysis of findings from twin and family studies.
- Inclusion of data from genome-wide association studies (GWAS).
Main Results:
- Rare mutations in APP, PSEN1, and PSEN2 are linked to early-onset familial AD (∼5% of cases).
- Common gene polymorphisms, notably APOE variants (ε4, ε2), affect susceptibility in late-onset AD (∼50% of cases).
- APP, PSEN1, PSEN2, and APOE genes explain 30%-50% of AD heritability; 11 additional AD candidate genes have been identified via GWAS.
Conclusions:
- Alzheimer disease has complex and heterogeneous genetic factors.
- Understanding these genetic influences is crucial for developing targeted AD therapies.
- Continued genetic research, including GWAS, is essential for further unraveling AD's etiology.
More Related Videos
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
What is Genetic Engineering?
Genetics of Speciation
What is Population Genetics?
Animal Mitochondrial Genetics